Nature Reviews Clinical Oncology

Vol. 22, Issue 1 Issue 1 2025
12
Articles

Articles in this Issue

Synthetic lethal strategies for the development of cancer therapeutics

Natalie Y. L. Ngoi, David Gallo, Carlos Torrado et al. Jan 01, 2025 pp. 46-64 10.1038/s41571-024-00966-z

Minimal residual disease as a target for liquid biopsy in patients with solid tumours

Klaus Pantel, Catherine Alix-Panabières Jan 01, 2025 pp. 65-77 10.1038/s41571-024-00967-y

Benefit with glofitamab plus chemotherapy in transplant-ineligible R/R DLBCL

Diana Romero Jan 01, 2025 pp. 2-2 10.1038/s41571-024-00975-y

An early switch in first-line therapy improves outcomes of advanced-stage G/GEJC

David Killock Jan 01, 2025 pp. 1-1 10.1038/s41571-024-00974-z

HIPEC is effective in patients undergoing cytoreduction for recurrent ovarian cancer

Peter Sidaway Jan 01, 2025 pp. 2-2 10.1038/s41571-024-00973-0

Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm

Paolo Ciracì, Vittorio Studiale, Ada Taravella et al. Jan 01, 2025 pp. 28-45 10.1038/s41571-024-00965-0

Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks

Caroline Diorio, David T. Teachey, Stephan A. Grupp Jan 01, 2025 pp. 10-27 10.1038/s41571-024-00959-y

First-line triplet therapy for advanced-stage PIK3CA-mutant HR+ breast cancer improves outcomes

David Killock Jan 01, 2025 pp. 1-1 10.1038/s41571-024-00968-x

Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?

Joshua Drago, Shanu Modi Jan 01, 2025 pp. 6-7 10.1038/s41571-024-00963-2

On the cusp of targeted therapy for cancer cachexia — what clinical benefits might we promise our patients?

Vickie E. Baracos Jan 01, 2025 pp. 8-9 10.1038/s41571-024-00964-1

Cadonilimab is effective and safe in recurrent cervical cancer

Diana Romero Jan 01, 2025 pp. 2-2 10.1038/s41571-024-00962-3

The TOPGEAR trial — is chemoradiotherapy no longer a component of multidisciplinary care for gastric cancer?

Brian Badgwell Jan 01, 2025 pp. 4-5 10.1038/s41571-024-00960-5

All Issues

Issue 7 - Issue 7 11 Issue 6 - Issue 6 10 Issue 5 - Issue 5 10 Issue 4 - Issue 4 10 Issue 3 - Issue 3 10 Issue 2 - Issue 2 9 Issue 1 - Issue 1 12
Issue 9 - Issue 9 11 Issue 8 - Issue 8 14 Issue 7 - Issue 7 10 Issue 6 - Issue 6 9 Issue 5 - Issue 5 11 Issue 4 - Issue 4 10 Issue 3 - Issue 3 12 Issue 2 - Issue 2 8 Issue 12 - Issue 12 13 Issue 11 - Issue 11 9 Issue 10 - Issue 10 8 Issue 1 - Issue 1 12

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page